Baxter International (BAX) News Today

Company: Baxter International Inc. (NYSE:BAX) shares have decreased today as the company reported a quarterly earnings miss, lowered its growth outlook and paused key product shipments.

• Positive Sentiment: Q2 revenue rose 4.3% year-over-year to $2.81 billion. Q2 Revenue Rises 4%
• Neutral Sentiment: MarketBeat reports an average “Hold” rating from nine brokerages covering BAX. MarketBeat Hold Ratings
• Neutral Sentiment: Wells Fargo cut its price target to $24 and assigned an “Equal Weight” rating. Benzinga
• Neutral Sentiment: The Goldman Sachs Group reaffirmed a Neutral rating with a $25 price target. Briefing.com
• Neutral Sentiment: TD Cowen maintained a Hold rating and lowered its price target to $26. TipRanks
• Negative Sentiment: BAX reported Q2 EPS of $0.59, missing the $0.60 consensus, and revenue of $2.81 billion vs. $2.82 billion expected. Zacks Q2 Miss
• Negative Sentiment: The company cut its FY 2025 EPS guidance to $2.42–$2.52 and Q3 EPS guidance to $0.58–$0.62, both below consensus. MarketBeat Guidance
• Negative Sentiment: Baxter paused infusion pump shipments amid quality and regulatory scrutiny. Becker's Hospital Review
• Negative Sentiment: Shares hit a new 52-week low after management lowered its growth forecast. InsiderMonkey
• Negative Sentiment: Baxter faces a lawsuit alleging toxic ethylene oxide emissions at its Chicago-area plant. Law.com